| Code | Description | Claims | Beneficiaries | Total Paid |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
2,182 |
1,929 |
$540K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
2,793 |
2,646 |
$428K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
559 |
508 |
$271K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
4,012 |
955 |
$153K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
578 |
513 |
$80K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
674 |
656 |
$67K |
| 87631 |
|
1,212 |
1,167 |
$57K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
826 |
785 |
$29K |
| 36415 |
Collection of venous blood by venipuncture |
11,919 |
8,284 |
$26K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
970 |
888 |
$21K |
| 80053 |
Comprehensive metabolic panel |
5,735 |
5,046 |
$20K |
| 71046 |
Radiologic examination, chest; 2 views |
428 |
415 |
$18K |
| 71045 |
Radiologic examination, chest; single view |
282 |
271 |
$18K |
| 84443 |
Thyroid stimulating hormone (TSH) |
2,148 |
2,096 |
$17K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
6,179 |
5,423 |
$16K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
97 |
68 |
$15K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
1,554 |
1,416 |
$14K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
306 |
272 |
$14K |
| 80061 |
Lipid panel |
1,235 |
1,225 |
$12K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
152 |
151 |
$11K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
309 |
105 |
$6K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
919 |
909 |
$5K |
| 0012A |
|
97 |
97 |
$4K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
988 |
918 |
$3K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
681 |
602 |
$3K |
| 0011A |
|
97 |
97 |
$3K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
60 |
58 |
$3K |
| 0013A |
|
48 |
48 |
$2K |
| 84439 |
|
371 |
365 |
$2K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
15 |
14 |
$2K |
| 81001 |
|
2,454 |
2,241 |
$2K |
| 87077 |
|
387 |
367 |
$2K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
360 |
326 |
$1K |
| 94762 |
|
29 |
26 |
$804.48 |
| 74019 |
|
14 |
13 |
$773.10 |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
12 |
12 |
$772.66 |
| 0001A |
|
19 |
18 |
$719.15 |
| 87081 |
|
183 |
183 |
$677.90 |
| 87181 |
|
290 |
273 |
$661.35 |
| 0003A |
|
13 |
13 |
$492.05 |
| 0002A |
|
13 |
13 |
$492.05 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
67 |
67 |
$467.12 |
| 83735 |
|
450 |
411 |
$457.00 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
25 |
25 |
$414.46 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
14 |
14 |
$388.64 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
14 |
14 |
$388.64 |
| 87400 |
|
62 |
62 |
$233.60 |
| 85610 |
|
284 |
263 |
$216.29 |
| 82728 |
|
24 |
24 |
$207.35 |
| 83690 |
|
459 |
422 |
$191.96 |
| 82607 |
|
12 |
12 |
$66.78 |
| 87070 |
|
12 |
12 |
$58.50 |
| 86140 |
|
36 |
31 |
$57.30 |
| 85027 |
|
36 |
34 |
$39.48 |
| 85730 |
|
123 |
120 |
$27.73 |
| 85651 |
|
13 |
13 |
$27.04 |
| 83605 |
|
251 |
231 |
$26.41 |
| 85007 |
|
39 |
36 |
$23.68 |
| 94760 |
|
654 |
599 |
$22.75 |
| 84703 |
|
63 |
61 |
$12.00 |
| 81025 |
|
12 |
12 |
$6.81 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
849 |
740 |
$0.00 |
| 94761 |
|
2,143 |
1,893 |
$0.00 |
| 84484 |
|
265 |
234 |
$0.00 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
249 |
240 |
$0.00 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
320 |
276 |
$0.00 |